866-997-4948(US-Canada Toll Free)

United States Capecitabine Market Report 2017

Published By :

QYResearch

Published Date : Jun 2017

Category :

Pharmaceutical

No. of Pages : 102 Pages

In this report, the United States Capecitabine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Capecitabine in these regions, from 2012 to 2022 (forecast).

United States Capecitabine market competition by top manufacturers/players, with Capecitabine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Roche
Tecoland
ScinoPharm
Aarti Group
Cipla
Intas
Hetero
Reliance Group
Guike Pharmaceutical

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Tablet
Capsule
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Capecitabine for each application, including
Breast Cancer
Rectal Cancer
Colon Cancer
Stomach Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Capecitabine Market Report 2017
1 Capecitabine Overview
1.1 Product Overview and Scope of Capecitabine
1.2 Classification of Capecitabine by Product Category
1.2.1 United States Capecitabine Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Capecitabine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Tablet
1.2.4 Capsule
1.3 United States Capecitabine Market by Application/End Users
1.3.1 United States Capecitabine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Breast Cancer
1.3.3 Rectal Cancer
1.3.4 Colon Cancer
1.3.5 Stomach Cancer
1.4 United States Capecitabine Market by Region
1.4.1 United States Capecitabine Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Capecitabine Status and Prospect (2012-2022)
1.4.3 Southwest Capecitabine Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Capecitabine Status and Prospect (2012-2022)
1.4.5 New England Capecitabine Status and Prospect (2012-2022)
1.4.6 The South Capecitabine Status and Prospect (2012-2022)
1.4.7 The Midwest Capecitabine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Capecitabine (2012-2022)
1.5.1 United States Capecitabine Sales and Growth Rate (2012-2022)
1.5.2 United States Capecitabine Revenue and Growth Rate (2012-2022)

2 United States Capecitabine Market Competition by Players/Suppliers
2.1 United States Capecitabine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Capecitabine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Capecitabine Average Price by Players/Suppliers (2012-2017)
2.4 United States Capecitabine Market Competitive Situation and Trends
2.4.1 United States Capecitabine Market Concentration Rate
2.4.2 United States Capecitabine Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Capecitabine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Capecitabine Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Capecitabine Sales and Market Share by Region (2012-2017)
3.2 United States Capecitabine Revenue and Market Share by Region (2012-2017)
3.3 United States Capecitabine Price by Region (2012-2017)

4 United States Capecitabine Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Capecitabine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Capecitabine Revenue and Market Share by Type (2012-2017)
4.3 United States Capecitabine Price by Type (2012-2017)
4.4 United States Capecitabine Sales Growth Rate by Type (2012-2017)

5 United States Capecitabine Sales (Volume) by Application (2012-2017)
5.1 United States Capecitabine Sales and Market Share by Application (2012-2017)
5.2 United States Capecitabine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Capecitabine Players/Suppliers Profiles and Sales Data
6.1 Roche
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Capecitabine Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Roche Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Tecoland
6.2.2 Capecitabine Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Tecoland Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 ScinoPharm
6.3.2 Capecitabine Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 ScinoPharm Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Aarti Group
6.4.2 Capecitabine Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Aarti Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Cipla
6.5.2 Capecitabine Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Cipla Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Intas
6.6.2 Capecitabine Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Intas Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Hetero
6.7.2 Capecitabine Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Hetero Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Reliance Group
6.8.2 Capecitabine Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Reliance Group Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Guike Pharmaceutical
6.9.2 Capecitabine Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Guike Pharmaceutical Capecitabine Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview

7 Capecitabine Manufacturing Cost Analysis
7.1 Capecitabine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Capecitabine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Capecitabine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Capecitabine Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Capecitabine Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Capecitabine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Capecitabine Sales Volume Forecast by Type (2017-2022)
11.3 United States Capecitabine Sales Volume Forecast by Application (2017-2022)
11.4 United States Capecitabine Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer


List of Table

List of Tables and Figures

Figure Product Picture of Capecitabine
Figure United States Capecitabine Market Size (K Pcs) by Type (2012-2022)
Figure United States Capecitabine Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablet Product Picture
Figure Capsule Product Picture
Figure United States Capecitabine Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Capecitabine by Application in 2016
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Rectal Cancer Examples
Table Key Downstream Customer in Rectal Cancer
Figure Colon Cancer Examples
Table Key Downstream Customer in Colon Cancer
Figure Stomach Cancer Examples
Table Key Downstream Customer in Stomach Cancer
Figure United States Capecitabine Market Size (Million USD) by Region (2012-2022)
Figure The West Capecitabine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Capecitabine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Capecitabine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Capecitabine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Capecitabine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Capecitabine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Capecitabine Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Capecitabine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Capecitabine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Capecitabine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Capecitabine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Capecitabine Sales Share by Players/Suppliers
Figure 2017 United States Capecitabine Sales Share by Players/Suppliers
Figure United States Capecitabine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Capecitabine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Capecitabine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Capecitabine Revenue Share by Players/Suppliers
Figure 2017 United States Capecitabine Revenue Share by Players/Suppliers
Table United States Market Capecitabine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Capecitabine Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Capecitabine Market Share of Top 3 Players/Suppliers
Figure United States Capecitabine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Capecitabine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Capecitabine Product Category
Table United States Capecitabine Sales (K Pcs) by Region (2012-2017)
Table United States Capecitabine Sales Share by Region (2012-2017)
Figure United States Capecitabine Sales Share by Region (2012-2017)
Figure United States Capecitabine Sales Market Share by Region in 2016
Table United States Capecitabine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Capecitabine Revenue Share by Region (2012-2017)
Figure United States Capecitabine Revenue Market Share by Region (2012-2017)
Figure United States Capecitabine Revenue Market Share by Region in 2016
Table United States Capecitabine Price (USD/Pcs) by Region (2012-2017)
Table United States Capecitabine Sales (K Pcs) by Type (2012-2017)
Table United States Capecitabine Sales Share by Type (2012-2017)
Figure United States Capecitabine Sales Share by Type (2012-2017)
Figure United States Capecitabine Sales Market Share by Type in 2016
Table United States Capecitabine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Capecitabine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Capecitabine by Type (2012-2017)
Figure Revenue Market Share of Capecitabine by Type in 2016
Table United States Capecitabine Price (USD/Pcs) by Types (2012-2017)
Figure United States Capecitabine Sales Growth Rate by Type (2012-2017)
Table United States Capecitabine Sales (K Pcs) by Application (2012-2017)
Table United States Capecitabine Sales Market Share by Application (2012-2017)
Figure United States Capecitabine Sales Market Share by Application (2012-2017)
Figure United States Capecitabine Sales Market Share by Application in 2016
Table United States Capecitabine Sales Growth Rate by Application (2012-2017)
Figure United States Capecitabine Sales Growth Rate by Application (2012-2017)
Table Roche Basic Information List
Table Roche Capecitabine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Capecitabine Sales Growth Rate (2012-2017)
Figure Roche Capecitabine Sales Market Share in United States (2012-2017)
Figure Roche Capecitabine Revenue Market Share in United States (2012-2017)
Table Tecoland Basic Information List
Table Tecoland Capecitabine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Tecoland Capecitabine Sales Growth Rate (2012-2017)
Figure Tecoland Capecitabine Sales Market Share in United States (2012-2017)
Figure Tecoland Capecitabine Revenue Market Share in United States (2012-2017)
Table ScinoPharm Basic Information List
Table ScinoPharm Capecitabine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ScinoPharm Capecitabine Sales Growth Rate (2012-2017)
Figure ScinoPharm Capecitabine Sales Market Share in United States (2012-2017)
Figure ScinoPharm Capecitabine Revenue Market Share in United States (2012-2017)
Table Aarti Group Basic Information List
Table Aarti Group Capecitabine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aarti Group Capecitabine Sales Growth Rate (2012-2017)
Figure Aarti Group Capecitabine Sales Market Share in United States (2012-2017)
Figure Aarti Group Capecitabine Revenue Market Share in United States (2012-2017)
Table Cipla Basic Information List
Table Cipla Capecitabine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cipla Capecitabine Sales Growth Rate (2012-2017)
Figure Cipla Capecitabine Sales Market Share in United States (2012-2017)
Figure Cipla Capecitabine Revenue Market Share in United States (2012-2017)
Table Intas Basic Information List
Table Intas Capecitabine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Intas Capecitabine Sales Growth Rate (2012-2017)
Figure Intas Capecitabine Sales Market Share in United States (2012-2017)
Figure Intas Capecitabine Revenue Market Share in United States (2012-2017)
Table Hetero Basic Information List
Table Hetero Capecitabine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Hetero Capecitabine Sales Growth Rate (2012-2017)
Figure Hetero Capecitabine Sales Market Share in United States (2012-2017)
Figure Hetero Capecitabine Revenue Market Share in United States (2012-2017)
Table Reliance Group Basic Information List
Table Reliance Group Capecitabine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Reliance Group Capecitabine Sales Growth Rate (2012-2017)
Figure Reliance Group Capecitabine Sales Market Share in United States (2012-2017)
Figure Reliance Group Capecitabine Revenue Market Share in United States (2012-2017)
Table Guike Pharmaceutical Basic Information List
Table Guike Pharmaceutical Capecitabine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Guike Pharmaceutical Capecitabine Sales Growth Rate (2012-2017)
Figure Guike Pharmaceutical Capecitabine Sales Market Share in United States (2012-2017)
Figure Guike Pharmaceutical Capecitabine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Capecitabine
Figure Manufacturing Process Analysis of Capecitabine
Figure Capecitabine Industrial Chain Analysis
Table Raw Materials Sources of Capecitabine Major Players/Suppliers in 2016
Table Major Buyers of Capecitabine
Table Distributors/Traders List
Figure United States Capecitabine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Capecitabine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Capecitabine Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Capecitabine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Capecitabine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Capecitabine Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Capecitabine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Capecitabine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Capecitabine Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Capecitabine Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Capecitabine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Capecitabine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Capecitabine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *